US-Canada joint inspection pilot shows savings of time-in-facility
This article was originally published in RAJ Devices
Executive Summary
A US-Canada pilot programme involving joint quality systems inspections of medical device companies by a single third party has revealed that around 33% less total time is spent at a manufacturer's facility when compared to the combined time of inspections performed individually to satisfy the regulatory requirements of each country1,2.
You may also be interested in...
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
WHO Examines Ethical Criteria For Human Challenge Trials Ahead Of Next Health Emergency
The World Health Organization is looking to finalize its guidance on the ethical criteria that should be applied to studies that involve deliberately infecting healthy individuals to speed up research.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.